IME

ImExHS Limited

About IME

ImExHS Limited (IME) is an innovative provider of medical imaging software and radiology services in 15 countries including Colombia, the US and Australia. Founded in 2012, IMEXHS develops software as a service (SaaS) imaging solutions that includes a Picture Archiving and Communications System (PACS), a Radiology Information System (RIS), a Cardiology Information System (CIS) and an Anatomical Pathology Laboratory Information System (APLIS). Its solutions are completely cloud-based, vendor neutral and zero footprint, with no need for installed software. The IMEXHS products are designed to increase productivity and save money for end users, with a scalable platform that enhances patient outcomes.

Buy Australian shares starting with IME. Invest today with a CHESS-sponsored broker!

Sector

Health Care

CEO

Industry

Health Care Technology

Website

imexhs.com

Market Capitalisation

$20M

Price-earnings ratio

-5.85

Dividend yield

0.00%

High today

$0.49

Low today

$0.49

Open price

$0.49

52-week high

$0.91

52-week low

$0.40

Announcements

IME FAQs

How much is one share of ImExHS Limited?

One share of ImExHS Limited is valued at $0.49.

What is the ticker symbol for ImExHS Limited?

The ticker symbol for ImExHS Limited is IME.

How do I buy IME shares in Australia?

To buy IME stocks in Australia you'll need to open an account with a broker like Stake.
To do so follow these steps:

Sign up in minutes, all you need is some I.D.
Choose Stake AUS
Deposit directly into your Stake wallet and you're ready to invest in IME

What is the 52-week high for ImExHS Limited stock?

The ImExHS Limited 52-week high stock price is $0.91.

What is the 52-week low for ImExHS Limited stock?

The ImExHS Limited 52-week low stock price is $0.40.

What is the market capitalisation of ImExHS Limited IME?

As of 26/03/2023 ImExHS Limited has a market cap of $20M.

Related Stocks

This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.